A 250-year sensory compounder with rare pricing power—Givaudan’s defensive “taste + fragrance” hedge meets tariff/FX headwinds at a compressed (but still premium) multiple.
Overview
Givaudan is the global leader in flavors and fragrances, combining centuries of heritage (since 1768) with modern bio-science and industrial-scale innovation. It holds ~25% global market share—well ahead of IFF, DSM-Firmenich, and Symrise—and functions as a strategic partner to major CPG leaders (Nestlé, P&G, Unilever, L’Oréal). Its two-division model—Taste & Wellbeing plus Fragrance & Beauty—acts as an internal hedge, balancing defensive food-related demand with premium fragrance exposure. After an exceptional 2024 recovery (12.3% LFL growth), growth normalized to 5.7% LFL in 9M 2025, still consistent with mid-term guidance. Crucially, profitability held up despite inflation/tariffs: gross margin stayed ~44% and H1 2025 EBITDA margin expanded to 25.2%, highlighting pricing power. The balance sheet remains strong (net debt/EBITDA ~2.5x). With shares around CHF 3,131 (~25x forward earnings), valuation is still premium but discounted versus historical levels, creating a long-term “quality compounder” entry point if macro concerns (tariffs/FX) fade.